IQVIA’s eCOA Solution Receives 2020 Fierce Innovation Award

  • Date 15 Sep 2020

IQVIA has announced that its electronic Clinical Outcome Assessment (eCOA) solution, an advanced-study build and execution platform that optimizes real-time, direct-from-patient data collection, has been selected as the winner of the Fierce Innovation Awards – Life Sciences Edition 2020 in the Digital Health Solutions category. The Fierce Innovation Awards is a peer-reviewed awards program produced by Questex, the publisher of Fierce Biotech and Fierce Pharma.

“We are honored to receive this prestigious award, which showcases outstanding innovation that is driving improvements and transforming the industry,” said Eric Hodgins, senior vice president, Real World Technology Solutions at IQVIA. “By building in the scientific expertise and intelligence needed within the eCOA technology and incorporating a truly agile development process, we are dramatically reducing the time to develop these tools while improving data quality and enhancing the patient experience.”

IQVIA eCOA is built on a highly secure, scalable SaaS platform that enables faster, flexible startup in clinical research and real world studies. IQVIA’s eCOA platform cuts up to three months from the industry standard eCOA development timeline while simultaneously improving the design through artificial intelligence-enabled design tools. This allows sponsors to launch trials faster and ensures the assessments will capture the right real-time insights to inform trial progress and demonstrate results.

IQVIA eCOA has a variety of capabilities that enhance the user experience and lead to time reductions, including a global library of pre-built assessments, which provides on-demand access to validated tools that can instantly be deployed. Currently, there are more than 850 assessments pre-configured in the library across a multitude of therapeutic areas.

The Fierce Innovation Awards go to companies that demonstrate innovative technologies and services with the potential to make the greatest impact for the life sciences industry. The awards program’s applications are reviewed by an exclusive panel of executives from major biotech and pharma companies. All honorees are evaluated based on effectiveness, technical innovation, competitive advantage, financial impact and true innovation.

Read more

Join an ambitious, supportive community of world-class scientists, engineers and entrepreneurs

Read more